Cancer Clinical Trial -Coordination Pharmaceuticals-CPI-300CL21-01

Cancer

Status:

Open

ClinicalTrials.gov:

NCT04808453

Phase I Study of CPI-300 in Patients With Advanced Tumors (CPI-300)

Drug

CPI-300

Phase

Phase I

Condition

Advanced Solid Tumors

Keywords

OxPt/SN38 Premature Release Inhibitor